Primary Keyword: Saudi Space Agency Reveals First Research Outcomes And Patent From SSA-HSF1 Mission

The Saudi Space Agency announced that 11 research papers and one patent had emerged from the Saudi space mission SSA-HSF1, launched in 2023. The output covered nine national and two international studies. The work drew on results from 19 scientific experiments carried out aboard the International Space Station by Saudi astronauts.

The agency reported that these experiments addressed three main tracks: biomedical sciences, human health, and science and technology. Several projects were developed with Saudi universities and international research centres. Scientific teams continued to analyse remaining data from SSA-HSF1, and the Saudi Space Agency stated that further findings would be shared with the global research community later.

Within the human health track, six experiments assessed how short missions in space affected the brain. Researchers monitored intracranial pressure through changes in pupil responses and tracked the optic nerve sheath diameter. Results showed notable changes during the flight, with increases in that diameter indicating raised intracranial pressure under microgravity conditions.

Additional human health experiments examined cerebral perfusion to understand how cognitive tasks behaved in microgravity. Scientists investigated how spaceflight influenced telomere length, working with international partners. The project aimed to detect changes linked to cellular ageing. The collected data improved knowledge of early ageing mechanisms and supported long-term planning for missions beyond low Earth orbit.

Biomedical research from SSA-HSF1 included a successful study using blood-based biomarkers to track human health in orbit. Another experiment produced a high-precision nanomaterial that exceeded Earth-based standards for cartilage repair. This material was developed with international research institutions, showing the value of collaboration for medical innovation under microgravity conditions.

The biomedical track also delivered the first gene transfer experiment for stem cells conducted in space, in partnership with international research centres. Scientists showed that simple and low-cost laboratory tools could support advanced medical work in orbit. This approach helped open paths toward new preventive protocols and possible treatments for neurological and immune-related diseases.

Saudi Space Agency science and technology experiments

In the science and technology track, researchers performed a cloud-seeding experiment in microgravity using a new technique not applied before. The trial assessed how water vapour reacted with silver iodide. Results demonstrated efficient interaction between both elements and produced new measurements on how gravity shaped water vapour condensation processes.

The cloud-seeding findings laid scientific foundations for more advanced weather modification technologies that could support water security. The Saudi Space Agency indicated that the results may help design climate solutions for Earth. The same knowledge might also guide environmental systems planned for future lunar bases and future missions to Mars.

{TABLE_1}

Saudi Space Agency mission goals and national strategy

The SSA-HSF1 mission turned the International Space Station into a high-value laboratory for Saudi researchers. Microgravity helped speed up some processes and improved the clarity of results. These efforts supported Saudi Vision 2030 goals that focused on scientific research, innovation, and localisation of technology within the Kingdom’s growing space sector.

During the mission, several tests recorded the brain’s electrical activity and monitored its integrity throughout the flight. Scientists evaluated new medical devices used in orbit for the first time. The precise datasets gained from these instruments contributed to methods for early detection of neurological conditions and deepened understanding of spaceflight-associated neuro-ocular syndrome.

Saudi Space Agency leadership and future space research

Spaceflight-associated neuro-ocular syndrome, known as SANS, remained a significant health concern for long missions. Data from SSA-HSF1 supported planning for exploratory journeys to the Moon and beyond. The Saudi Space Agency stressed that continued analysis of mission data would feed into future experiments and inform international standards for astronaut health.

Acting CEO of the SSA Dr. Mohammed Al-Tamimi stated that the announced results mark an important milestone in the Kingdom’s journey toward leadership in space research. He added that the announcement reflects the Kingdom’s commitment to leading advanced research efforts that serve humanity and strengthen international partnerships in science and technology.

Al-Tamimi emphasized the SSA’s commitment to empowering national talent, expanding scientific collaboration, and translating research outcomes into practical applications that deliver tangible benefits both on Earth and in space. The agency said that the new findings strengthened Saudi Arabia’s role as a regional and global centre for science, technology, and sustainable space exploration.

With inputs from SPA